Oncology & Cancer

Knocking out deadly brain cancer with a dual therapy

Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma ...

Genetics

Study uncovers genetic risk factors for heart failure

In a new study co-led by investigators at the United States Department of Veterans Affairs and Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, a global team of scientists conducted ...

Medications

Epstein-Barr virus associated tumors and drug repurposing

A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...

Genetics

Multiomics study of nonalcoholic fatty liver disease

Scientists at deCODE genetics, a subsidiary of Amgen, published today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were ...

Oncology & Cancer

How common genetic alterations cause kidney cancer

An international group of researchers investigated why mutations often associated with renal cancer result specifically in renal cancer, instead of other cancer types.

page 1 from 3